People: Myriad Genetics Inc (MYGN.O)

MYGN.O on Nasdaq

33.20USD
26 Nov 2014
Price Change (% chg)

$-0.05 (-0.15%)
Prev Close
$33.25
Open
$33.30
Day's High
$33.43
Day's Low
$32.85
Volume
265,807
Avg. Vol
754,723
52-wk High
$42.50
52-wk Low
$20.02

Search Stocks

Lanchbury, Jerry 

Brief Biography

Dr. Jerry S. Lanchbury Ph.D. is Chief Scientific Officer of Myriad Genetics, Inc. In July 2005 he was appointed Executive Vice President of Research, a position he held until he was named Chief Scientific Officer in February 2010. Dr. Lanchbury came to us from GKT School of Medicine, King’s College where he had served as Reader in Molecular Immunogenetics and Head of Molecular Immunogenetics Unit since 1997. Dr. Lanchbury earned his Ph.D. from the University of Newcastle upon Tyne and 1st Class Honours, B.Sc. “Biology of Man & his Environment” degree from the University of Aston.

Basic Compensation

Total Annual Compensation, USD Long-Term Incentive Plans, USD All Other, USD Fiscal Year Total, USD
733,643 -- 1,855,300 2,588,940

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised 105,786 2,156,310.00
Name Fiscal Year Total

John Henderson

--

Peter Meldrum

8,142,070

Walter Gilbert

--

Mark Capone

4,512,060

Richard Marsh

2,691,610

Jayne Hart

--
As Of 29 Jun 2014
Search Stocks